NCT00881894View on ClinicalTrials.gov

Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

Rotigotine transdermal patch

Rotigotine 4.5mg/10cm\^2 patch applied for 24 hours

Trial Locations (1)

Unknown

Neuss

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY